US Stock MarketDetailed Quotes

ALNAQ Allena Pharmaceuticals

Watchlist

0.000
0.0000.00%

15min DelayClose Dec 14 09:30 ET

122.08Market Cap0.00P/E (TTM)

Allena Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

(Q3)Sep 30, 2021

(Q2)Jun 30, 2021

(Q1)Mar 31, 2021

(FY)Dec 31, 2020

(Q4)Dec 31, 2020

(Q3)Sep 30, 2020

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-49.41%6.92M

1.29%11.56M

48.97%47.65M

1.36%10.12M

57.00%12.43M

108.68%13.69M

51.65%11.41M

-31.83%31.99M

-6.58%9.99M

-40.64%7.92M

Selling and administrative expenses

-18.18%2.94M

6.77%3.8M

9.26%12.68M

-29.69%2.12M

14.87%3.41M

30.75%3.6M

23.63%3.56M

19.92%11.6M

52.92%3.01M

17.14%2.97M

-General and administrative expense

-18.18%2.94M

6.77%3.8M

9.26%12.68M

-29.69%2.12M

14.87%3.41M

30.75%3.6M

23.63%3.56M

19.92%11.6M

52.92%3.01M

17.14%2.97M

Research and development costs

-60.55%3.98M

-1.20%7.76M

71.57%34.97M

14.75%8.01M

82.23%9.02M

164.97%10.09M

69.01%7.85M

-45.27%20.38M

-20.00%6.98M

-54.17%4.95M

Operating profit

49.41%-6.92M

-1.29%-11.56M

-48.97%-47.65M

-1.36%-10.12M

-57.00%-12.43M

-108.68%-13.69M

-51.65%-11.41M

31.83%-31.99M

6.58%-9.99M

40.64%-7.92M

Net non-operating interest income expense

53.36%-118K

-5.96%-249K

-91.37%-976K

4.42%-238K

-140.38%-250K

-145.63%-253K

-335.19%-235K

-288.89%-510K

-1,975.00%-249K

-296.23%-104K

Non-operating interest expense

-53.36%118K

5.96%249K

----

140.38%250K

145.63%253K

335.19%235K

----

--104K

Total other finance cost

----

91.37%976K

----

288.89%510K

----

Other net income (expense)

-4,253.13%-1.39M

-177.78%-7K

89.11%-38K

83.33%-4K

-175.00%-11K

89.81%-32K

228.57%9K

49.35%-349K

96.36%-24K

-33.33%-4K

Gain on sale of security

---1.02M

----

Special income (charges)

----

--0

----

--0

----

-Less：Restructuring and merger&acquisition

----

--0

----

--0

----

Other non- operating income (expenses)

-1,056.25%-370K

-177.78%-7K

89.11%-38K

83.33%-4K

-175.00%-11K

89.81%-32K

228.57%9K

-315.48%-349K

55.56%-24K

-33.33%-4K

Income before tax

39.63%-8.44M

-1.52%-11.81M

-48.16%-48.66M

-1.02%-10.36M

-58.14%-12.69M

-100.29%-13.97M

-53.41%-11.64M

30.62%-32.85M

9.69%-10.26M

39.60%-8.03M

Income tax

Net income

39.63%-8.44M

-1.52%-11.81M

-48.16%-48.66M

-1.02%-10.36M

-58.14%-12.69M

-100.29%-13.97M

-53.41%-11.64M

30.62%-32.85M

9.69%-10.26M

39.60%-8.03M

Net income continuous Operations

39.63%-8.44M

-1.52%-11.81M

-48.16%-48.66M

-1.02%-10.36M

-58.14%-12.69M

-100.29%-13.97M

-53.41%-11.64M

30.62%-32.85M

9.69%-10.26M

39.60%-8.03M

Minority interest income

Net income attributable to the parent company

39.63%-8.44M

-1.52%-11.81M

-48.16%-48.66M

-1.02%-10.36M

-58.14%-12.69M

-100.29%-13.97M

-53.41%-11.64M

30.62%-32.85M

9.69%-10.26M

39.60%-8.03M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

39.63%-8.44M

-1.52%-11.81M

-48.16%-48.66M

-1.02%-10.36M

-58.14%-12.69M

-100.29%-13.97M

-53.41%-11.64M

30.62%-32.85M

9.69%-10.26M

39.60%-8.03M

Basic earnings per share

66.67%-0.08

38.10%-0.13

28.71%-0.72

54.17%-0.11

22.73%-0.17

7.69%-0.24

32.26%-0.21

52.58%-1.01

48.94%-0.24

61.40%-0.22

Diluted earnings per share

66.67%-0.08

38.10%-0.13

28.71%-0.72

54.17%-0.11

22.73%-0.17

7.69%-0.24

32.26%-0.21

52.58%-1.01

48.94%-0.24

61.40%-0.22

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021	(Q3)Sep 30, 2021	(Q2)Jun 30, 2021	(Q1)Mar 31, 2021	(FY)Dec 31, 2020	(Q4)Dec 31, 2020	(Q3)Sep 30, 2020
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-49.41%6.92M	1.29%11.56M	48.97%47.65M	1.36%10.12M	57.00%12.43M	108.68%13.69M	51.65%11.41M	-31.83%31.99M	-6.58%9.99M	-40.64%7.92M
Selling and administrative expenses	-18.18%2.94M	6.77%3.8M	9.26%12.68M	-29.69%2.12M	14.87%3.41M	30.75%3.6M	23.63%3.56M	19.92%11.6M	52.92%3.01M	17.14%2.97M
-General and administrative expense	-18.18%2.94M	6.77%3.8M	9.26%12.68M	-29.69%2.12M	14.87%3.41M	30.75%3.6M	23.63%3.56M	19.92%11.6M	52.92%3.01M	17.14%2.97M
Research and development costs	-60.55%3.98M	-1.20%7.76M	71.57%34.97M	14.75%8.01M	82.23%9.02M	164.97%10.09M	69.01%7.85M	-45.27%20.38M	-20.00%6.98M	-54.17%4.95M
Operating profit	49.41%-6.92M	-1.29%-11.56M	-48.97%-47.65M	-1.36%-10.12M	-57.00%-12.43M	-108.68%-13.69M	-51.65%-11.41M	31.83%-31.99M	6.58%-9.99M	40.64%-7.92M
Net non-operating interest income expense	53.36%-118K	-5.96%-249K	-91.37%-976K	4.42%-238K	-140.38%-250K	-145.63%-253K	-335.19%-235K	-288.89%-510K	-1,975.00%-249K	-296.23%-104K
Non-operating interest expense	-53.36%118K	5.96%249K	----	----	140.38%250K	145.63%253K	335.19%235K	----	----	--104K
Total other finance cost	----	----	91.37%976K	----	----	----	----	288.89%510K	----	----
Other net income (expense)	-4,253.13%-1.39M	-177.78%-7K	89.11%-38K	83.33%-4K	-175.00%-11K	89.81%-32K	228.57%9K	49.35%-349K	96.36%-24K	-33.33%-4K
Gain on sale of security	---1.02M	----	----	----	----	----	----	----	----	----
Special income (charges)	----	----	--0	----	----	----	----	--0	----	----
-Less：Restructuring and merger&acquisition	----	----	--0	----	----	----	----	--0	----	----
Other non- operating income (expenses)	-1,056.25%-370K	-177.78%-7K	89.11%-38K	83.33%-4K	-175.00%-11K	89.81%-32K	228.57%9K	-315.48%-349K	55.56%-24K	-33.33%-4K
Income before tax	39.63%-8.44M	-1.52%-11.81M	-48.16%-48.66M	-1.02%-10.36M	-58.14%-12.69M	-100.29%-13.97M	-53.41%-11.64M	30.62%-32.85M	9.69%-10.26M	39.60%-8.03M
Income tax
Net income	39.63%-8.44M	-1.52%-11.81M	-48.16%-48.66M	-1.02%-10.36M	-58.14%-12.69M	-100.29%-13.97M	-53.41%-11.64M	30.62%-32.85M	9.69%-10.26M	39.60%-8.03M
Net income continuous Operations	39.63%-8.44M	-1.52%-11.81M	-48.16%-48.66M	-1.02%-10.36M	-58.14%-12.69M	-100.29%-13.97M	-53.41%-11.64M	30.62%-32.85M	9.69%-10.26M	39.60%-8.03M
Minority interest income
Net income attributable to the parent company	39.63%-8.44M	-1.52%-11.81M	-48.16%-48.66M	-1.02%-10.36M	-58.14%-12.69M	-100.29%-13.97M	-53.41%-11.64M	30.62%-32.85M	9.69%-10.26M	39.60%-8.03M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	39.63%-8.44M	-1.52%-11.81M	-48.16%-48.66M	-1.02%-10.36M	-58.14%-12.69M	-100.29%-13.97M	-53.41%-11.64M	30.62%-32.85M	9.69%-10.26M	39.60%-8.03M
Basic earnings per share	66.67%-0.08	38.10%-0.13	28.71%-0.72	54.17%-0.11	22.73%-0.17	7.69%-0.24	32.26%-0.21	52.58%-1.01	48.94%-0.24	61.40%-0.22
Diluted earnings per share	66.67%-0.08	38.10%-0.13	28.71%-0.72	54.17%-0.11	22.73%-0.17	7.69%-0.24	32.26%-0.21	52.58%-1.01	48.94%-0.24	61.40%-0.22
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data